<DOC>
<DOCNO>
EP-0011928
</DOCNO>
<TEXT>
<DATE>
19800611
</DATE>
<IPC-CLASSIFICATIONS>
A61P-3/06 C07C-69/73 C07C-69/732 A61K-31/215 C07C-69/712 A61P-3/00 C07C-67/30 C07C-69/00 <main>C07C-69/675</main> A61K-31/21 C07C-67/00 A61K-31/22 
</IPC-CLASSIFICATIONS>
<TITLE>
3,5-dihydroxypentanoic ester derivatives having antihyperlipaemic activity, their manufacture and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
sankyo co jp  <sep>sankyo company limited<sep>sankyo company limitedno. 1-6, 3-chome nihonbashi honcho chuo-kutokyojp<sep>sankyo company limited<sep>
</APPLICANT>
<INVENTOR>
endo akira fermentation resear<sep>oka hidehiko fermentation rese<sep>terahara akira fermentation re<sep>endo, akira fermentation research<sep>oka, hidehiko fermentation research<sep>terahara, akira fermentation research<sep>endo, akira fermentation researchlaboratories sankyo co.,ltd., 2-58, 1-chomehiromachi shinagawa-ku, tokyojp<sep>oka, hidehiko fermentation researchlaboratories sankyo co.,ltd., 2-58, 1-chomehiromachi shinagawa-ku, tokyojp<sep>terahara, akira fermentation researchlaboratories sankyo co.,ltd., 2-58, 1-chomehiromachi shinagawa-ku, tokyojp<sep>endo, akira fermentation research<sep>oka, hidehiko fermentation research<sep>terahara, akira fermentation research<sep>endo, akira fermentation researchlaboratories sankyo co.,ltd., 2-58, 1-chomehiromachi shinagawa-ku, tokyojp<sep>oka, hidehiko fermentation researchlaboratories sankyo co.,ltd., 2-58, 1-chomehiromachi shinagawa-ku, tokyojp<sep>terahara, akira fermentation researchlaboratories sankyo co.,ltd., 2-58, 1-chomehiromachi shinagawa-ku, tokyojp<sep>
</INVENTOR>
<ABSTRACT>
3,5-dihydroxypentanoic ester derivatives of formula (i):   z-a--ch₂--ch₂-coor (i)    (wherein:   a represents an alkylene group which is optionally substi­ tuted by one or more alkyl groups, or an alkenylene group;   z represents a substituted or unsubstituted aryl or  aryloxy group; and   r represents a c₁ - c₄ alkyl group)   may be prepared by reacting a dianion of an acetoacetic ester  with an aldehyde of formula z-a-cho (wherein a and z are as  defined above) and then reducing the resulting compound.   these 3,5-dihydroxypentanoic ester derivatives have anti­ hyperlipaemic activity and are thus valuable pharmaceuticals.  
</ABSTRACT>
</TEXT>
</DOC>
